Tag Archives: checkpoint inhibitor

June, 2016

• 17 June

  Scancell Halts Melanoma Vaccine Trial due to Drug Problems

  

  Scancell Holdings Plc, (AIM:SCLP), the developer of novel Immunotherapies for the treatment of cancer, announces that it is suspending dosing with the current clinical trial supplies of SCIB1 with immediate effect. Ongoing quality control analysis has revealed that the stored drug product is no longer within the original specification. In discussion with …

  Share

  • Facebook
  • Twitter
  • LinkedIn

February, 2016

• 24 February

  Regen BioPharma Completes Preclinical Experimentation of its Novel siRNA NR2F6 Checkpoint Inhibitor

  

  SAN DIEGO, February 24, 2016 /PRNewswire/ — Regen BioPharma, Inc., (OTCBB: RGBP) and (PINK: RGBP) announced today completion of experiments, in collaboration with Dr.Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach.  Subsequent to these experiments, the Company has begun the process of compiling an Investigational New Drug …

  Share

  • Facebook
  • Twitter
  • LinkedIn